Knicks · Building a Better KP Dr Carlon Colker (page 1)
CrushAlot wrote:Not fair... I remember that vividly. McDyess looked amazing. He was just getting his reps in. His knee blew out because it was going to blow out, not because of anything ANYBODY did wrong. Cmon manmartin wrote:Yeah. See McDyess still playing in the final minutes of a preseason game coming back from a major knee injury.Gudris wrote:He will be back by the opening night, maybe restricted minutes but he will playNo. He. Won't. That's just stupid
That was a real turning point in Knick history. Remember Chaney won 37 games with that team with a frontline of Spoon/Harrington/Kurt. Also they started 1-8 when Spree started late with some injury so even without McDyess they were a .500 team when Spree came back. McDyess looked like a beast in that game. It was easy to see why management was so enticed. If McDyess was healthy with him, Houston and Spree and some decent role player Knicks would have been at worst a top 4 team in the east and by MSG standards that alone is like winning a title. Needless to say that trade accomplished nothing but start the downward spiral of trading picks for role players and busts. Houston and Spree were at the top of their games. It would have been fun to see that group with KT playing a kind of stretch 5 
Ephedra Edit
Colker has generated controversy regarding his public comments and research on the safety of ephedra-based dietary supplements. Colker was the lead researcher responsible for studies and product development on behalf of supplement manufacturers such as Cytodyne Technologies,[1][32][33][34] Muscletech Research and Development,[35] and Metabolife International, manufacturers of the ephedra-based weight loss pills Xenadrine RFA-1, Hydroxycut, and Metabolife 365, respectively.[2][24]
Following the February 2003 heatstroke-related death of Baltimore Orioles pitcher Steve Bechler, in which ephedra was implicated as the cause,[36] Colker and two other physicians, all speaking on behalf of the industry-affiliated Ephedra Education Council, disputed the role that ephedra played in Bechler’s death.[3][4] Colker also downplayed the dangers of ephedra, claiming that it "is not a health risk for most people".[5]
In May 2003, a California Superior Court judge handed down a $12.5 million judgment in a class action suit against Cytodyne Technologies for falsely advertising Xenadrine RFA-1, the product implicated in the death of Bechler. Colker had been enlisted by Cytodyne to conduct a clinical study on the effectiveness of Xenadrine RFA-1, and upon the study’s completion, the company paid Colker approximately $5,000 to field calls from customers and make conference appearances.[1] Referring to Colker's research, the judge noted that Colker lacked credibility[1] and concluded that Cytodyne had "not just exaggerated the findings of the clinical trials it commissioned, but had also cajoled some researchers into fudging results", and that those involved in the research on Xenadrine RFA-1 had set out "to create a study that justified the money being spent by Cytodyne and that would ensure that they received further work from the company". Journalists for the New York Times commenting on Cytodyne's research noted that the legal case raised "serious questions about the way makers of ephedra and other dietary supplements use -- and often misuse -- the promise of scientific proof to market their products".[2]
During 2003, Colker was named as a defendant in lawsuits filed in Missouri, West Virginia, and Illinois in connection with his involvement in the research and marketing of Hydroxycut and Xenadrine RFA-1. The lawsuits alleged that Colker and his Greenwich clinic, Peak Wellness Inc., ran fraudulent tests, altered test results, and hid dangerous adverse reactions suffered by test subjects.[6][7]
[9][10][37] In July 2003, Colker was called to testify before a United States House Committee on Energy and Commerce investigating deaths and adverse events stemming from ephedra supplements for which Colker had been involved in researching and marketing.[32][33]
V-Factor Edit
Colker previously served as a researcher and television spokesperson for “V-Factor” (a combination of yohimbine, L-arginine, and Gingko biloba), a dietary supplement marketed by Vital Basics, Inc. of Portland, Maine as a men’s sexual performance enhancer. In 2004, the U.S. Federal Trade Commission registered a complaint against Vital Basics and its owners[11][12] alleging, in part, that the company’s advertising of V-Factor violated Federal law; specifically, that the company made unsubstantiated claims about V-Factor’s safety; falsely represented that a clinical study of V-Factor conducted by Colker proved that the product was safe and effective; and misrepresented paid commercial advertising featuring Colker (Vital Basics Health Show radio infomercials) as independent radio programs. The defendants settled the FTC’s complaint by paying $1 million for consumer redress and agreeing not to make unsubstantiated claims in the future.[13][38]
dacash wrote:Colder might be a crook too lol hope its just crap but its soooo Knicks lolEphedra Edit
Colker has generated controversy regarding his public comments and research on the safety of ephedra-based dietary supplements. Colker was the lead researcher responsible for studies and product development on behalf of supplement manufacturers such as Cytodyne Technologies,[1][32][33][34] Muscletech Research and Development,[35] and Metabolife International, manufacturers of the ephedra-based weight loss pills Xenadrine RFA-1, Hydroxycut, and Metabolife 365, respectively.[2][24]Following the February 2003 heatstroke-related death of Baltimore Orioles pitcher Steve Bechler, in which ephedra was implicated as the cause,[36] Colker and two other physicians, all speaking on behalf of the industry-affiliated Ephedra Education Council, disputed the role that ephedra played in Bechler’s death.[3][4] Colker also downplayed the dangers of ephedra, claiming that it "is not a health risk for most people".[5]
In May 2003, a California Superior Court judge handed down a $12.5 million judgment in a class action suit against Cytodyne Technologies for falsely advertising Xenadrine RFA-1, the product implicated in the death of Bechler. Colker had been enlisted by Cytodyne to conduct a clinical study on the effectiveness of Xenadrine RFA-1, and upon the study’s completion, the company paid Colker approximately $5,000 to field calls from customers and make conference appearances.[1] Referring to Colker's research, the judge noted that Colker lacked credibility[1] and concluded that Cytodyne had "not just exaggerated the findings of the clinical trials it commissioned, but had also cajoled some researchers into fudging results", and that those involved in the research on Xenadrine RFA-1 had set out "to create a study that justified the money being spent by Cytodyne and that would ensure that they received further work from the company". Journalists for the New York Times commenting on Cytodyne's research noted that the legal case raised "serious questions about the way makers of ephedra and other dietary supplements use -- and often misuse -- the promise of scientific proof to market their products".[2]
During 2003, Colker was named as a defendant in lawsuits filed in Missouri, West Virginia, and Illinois in connection with his involvement in the research and marketing of Hydroxycut and Xenadrine RFA-1. The lawsuits alleged that Colker and his Greenwich clinic, Peak Wellness Inc., ran fraudulent tests, altered test results, and hid dangerous adverse reactions suffered by test subjects.[6][7]
V-Factor Edit
Colker previously served as a researcher and television spokesperson for “V-Factor” (a combination of yohimbine, L-arginine, and Gingko biloba), a dietary supplement marketed by Vital Basics, Inc. of Portland, Maine as a men’s sexual performance enhancer. In 2004, the U.S. Federal Trade Commission registered a complaint against Vital Basics and its owners[11][12] alleging, in part, that the company’s advertising of V-Factor violated Federal law; specifically, that the company made unsubstantiated claims about V-Factor’s safety; falsely represented that a clinical study of V-Factor conducted by Colker proved that the product was safe and effective; and misrepresented paid commercial advertising featuring Colker (Vital Basics Health Show radio infomercials) as independent radio programs. The defendants settled the FTC’s complaint by paying $1 million for consumer redress and agreeing not to make unsubstantiated claims in the future.[13][38]
Colker is not employed by the knicks. He is by KP.
I would not take his bravado that KP will be ready next week to play if knicks were in the playoffs (I'm exaggerating) but at the same time not totally blow off his life as a crook.
He no doubt has hawked supplements in an aggressive manner in an area not well regulated and has had his hand slapped. Ephedria was widespread used by many many companies in their products. I used it a product that was very well used and had a good reputation. That said, I was careful about my intake.
Eddy's problems were likely caused by his over use.
Im glad its off the market.
I won't vouch for this dude at all, but as long as KP is careful as is Colker with our unicorn I have no problem with him.